Results 11 to 20 of about 391,709 (316)
Vasopressin receptor antagonists [PDF]
The first non-peptide vasopressin receptor antagonist (VRA) was recently approved by the United States Food and Drug Administration, and several others are now in late stages of clinical development. Phase 3 trials indicate that these agents predictably reduce urine osmolality, increase electrolyte-free water excretion, and raise serum sodium ...
Arthur Greenberg, Joseph G. Verbalis
openaire +3 more sources
Aldosterone receptor antagonists [PDF]
Blocking the mineralocorticoid receptor (MR) is one of the most effective ways of reducing blood pressure in patients with resistant hypertension and improving cardiovascular prognosis in patients with heart failure with reduced ejection fraction and left ventricular dysfunction after myocardial infarction.
openaire +4 more sources
Leukotriene Receptor Antagonists [PDF]
In the past decade, heightened emphasis has been placed on the importance of inflammation in the pathogenesis of asthma. Although corticosteroids have remained the primary anti-inflammatory agents in the management of the persistent asthmatic, new classes of drugs have recently been added.
Nizar J. Jarjour, Marzena E. Krawiec
openaire +3 more sources
Mineralocorticoid Receptor Antagonists [PDF]
Two mineralocorticoid receptor antagonists, spironolactone and eplerenone, are currently approved by the FDA. Several non-steroid based ligands are in clinical trials for indications including heart failure, hypertension and diabetic kidney disease, and even more structurally distinct chemical series are reported in the literature with preclinical data
Kenneth Granberg, Anneli Nordqvist
openaire +5 more sources
Endothelin Receptors and Their Antagonists
All three members of the endothelin (ET) family of peptides, ET-1, ET-2, and ET-3, are expressed in the human kidney, with ET-1 being the predominant isoform. ET-1 and ET-2 bind to two G-protein-coupled receptors, ETA and ETB, whereas at physiological concentrations ET-3 has little affinity for the ET(A) receptor.
Maguire, Janet J, Davenport, Anthony P
openaire +4 more sources
Olfaction: Receptor Antagonistes [PDF]
Odor receptors of the mammalian olfactory system have long been known to be activated in combinatorial fashion by odorants. A large-scale study now reveals that inhibition of receptors by odorants is comparably prevalent and combinatorial.
Douglas Rioux, John R. Carlson
openaire +2 more sources
Correlation of Histamine Receptors and Adrenergic Receptor in Broilers Appetite [PDF]
The current study was conducted to investigate the interaction between the central adrenergic and histaminergic systems and the broiler chick’s feed intake.
M Daneshvar+3 more
doaj +1 more source
Several evidences indicate that the ubiquitous nucleoside adenosine, acting through A1, A2A, A2B, and A3 receptor (AR) subtypes, plays crucial roles in tumor development. Adenosine has contrasting effects on cell proliferation depending on the engagement
Stefania Gessi+9 more
doaj +1 more source
Involvement of central opiate receptors in modulation of centrally administered oxytocin-induced antinociception [PDF]
Objective(s): Oxytocin is involved in modulation of many brain-mediated functions. In the present study, we investigated the central effects of oxytocin and its receptor antagonist, atosiban on inflammatory pain.
Amir Erfanparast+2 more
doaj +1 more source
The relevance of theobromine for the beneficial effects of cocoa consumption
Cocoa consumption began in America and in the mid 16th Century it quickly spread to Europe. Beyond being considered a pleasant habit due to its rich sweet lingering taste, chocolate was considered a good nutrient and even a medicine.
Eva eMartínez-Pinilla+2 more
doaj +1 more source